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1 INTRODUCTION 
Glycine (Gly) exhibits various vitally important
functions in the body [1−9]. It was found in various
proteins and biologically active proteins; it is an
immediate precursor for synthesis of the heme por
phyrin moiety and a component for synthesis of purine
bases [10]. This amino acid is also involved in regula
tion of neurotransmitter synaptic transmission and the
central and peripheral nervous system [1, 7]. Gly
receptors localized in various regions of the brain and
spinal cord mediated the inhibitory action on neurons
and thus reduce release of excitatory amino acids
[1⎯3]. Gly also acts as a coagonist of γamino
butyrate receptor (GABAR) and glutamate NMDA
receptor (NMDAR) [4−8]. 
Although Glybased pharmacological preparations
demonstrate a wide range of positive effects (e.g.,
improvement of memory and associative processes,
the antidepressant action, reduced feelings of anxiety,
fear, psychoemotional stress, etc.), mechanisms
responsible for their realization still require better
understanding and in most even the best studied links
of these mechanisms are based on numerous hypothe
sis rather than welldocumented facts. 
Possible Gly effects on viability of cultured nervous
tissue cells remain poorly investigated as most studies
in this field do investigate bioelectric activity of cell
membranes influenced by Gly as a neurotransmitter
[7−9, 11, 12]. 
However, it has been recently demonstrated that
Gly in the range of concentrations from 0.01 to
25.0 mM attenuates degenerative processes in the spi
1 To whom correspondence should be addressed. 
nal cord cell layer and C6 glioma induced by serum
(trophic factor) deprivation [13−20]. During the
whole period of observation (72 h) decreased activity
of 2calpain (EC 3.4.22.53), lactate dehydrogenase
(EC 1.1.1.27) was registered in cells and conditioned
media of these cultures; this was also accompanied by
decreased cell death and maintenance of proliferative
activity in the nerve tissue cells [13−19]. Gly addition
also caused a 2⎯7fold increase in spinal cord cell sur
vival [20]. Under conditions of prolonged serum dep
rivation in the cultural medium 0.1 mM Gly exhibited
the mitogenic effect on rat spinal cord cells (14 days in
vitro): there was an increase in cell DNA content and
appearance of young neurons in the culture [13, 16]. 
It was found that Gly critically influenced plasmi
nogen effects. For example, 0.01 or 0.1 mM Gly added
together with plasminogen (10–7 M) potentiated the
protector effect of this zymogen on C6 and spinal cord
cells; in the presence of 10–8 M plasminogen Gly
increased the stimulating effect of this zymogen on C6
glioma cells. The stabilizing action was observed at
both morphofunctional and metabolic effects [14,
17, 20–22].
These numerous Gly effects on the nervous tissue
in vitro suggest a very important role of this amino acid
for regulation of viability of nervous tissue cells (par
ticularly, changes in cell cycle, cell protection against
various damaging factors, principal changes in the
mode of action of proteins exhibiting neurotrophic
(plasminogenlike) properties on target cells. Detailed
elucidation of their mechanisms will clearly open per
spectives for subsequent multidisciplinary studies. 
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1. GLYCINE METABOLISM 
IN THE NERVOUS TISSUE
Although glycine has been identified in proteins
more than 200 years ago, studies on its dynamic con
tent in various brain structures still cause scientific
debates [23, 24]. 
Brain content of Gly (and GABA as well) prevails
(in the reducing order) in such structures as midbrain,
thalamus, cerebellum, temporal cortex, and corpus
collosum [24]. It is generally accepted that the brain
content of free Gly is normally 1.3 μM and in the cere
brospinal fluid it is two orders of magnitude less. Since
Gly consumption in the nervous tissue is rather high
and its supply from blood occurs rather slowly, the
brain synthesizes a significant proportion of Gly de
novo [25]. 
Glucose and serine are the major sources for Gly
biosynthesis in the central nervous system (CNS) [24].
Serine may be formed from glucose via 3phospho
glycerate formation; in addition, it is readily pene
trates from blood circulation into the brain across the
blood brain barrier. In the nervous tissue Gly synthesis
de novo involves serine hydroxymethyltransferase
(EC 2.1.2.1) [25]. High activity of this enzyme was
found in metabolic pools of the brain and spinal cord,
for example, in the cerebellum and the anterior horn
of the spinal cored. Serine hydroxymethyltransferase
activity correlated first of all with glycine content in
these structures [2]. 
Two other sources for Gly synthesis in the human
and animal nervous systems include glutamate and
glyoxylate [24]. Since brain glutamate concentration
(about 10.6 μM) is the highest among amino acids,
while glyoxylate concentrations are insignificant,
glutamate makes the major contribution to Gly for
mation. Glutamine, a precursor of both excitatory
(Glu, Asp) and inhibitory (GABA, Gly) amino acid
neurotransmitters enters neurons from the glia [26]. 
At least three pathways of Gly catabolism do exist
in the nervous tissue [24]. The first one is based on
reversibility of the reaction of Ser conversion into Gly
in the brain tissue and therefore serine hydroxymeth
yltransferase may act as the Gly metabolizing enzyme
[24, 27]. The second pathway involves oxidases of
amino acids (EC 1.4.3.2, 1.4.3.3); in the CNS these
highly abundant enzymes use Gly and other amino
acids as substrates [24, 27, 28]. The third system of Gly
cleavage is localized only in mitochondria and is atyp
ical amino acid decarboxylase as its activity depends
on both NAD+ and tetrahydrofolate (THF) [24]. The
Gly cleavage system catalyzes Gly cleavage into meth
ylenetetrahydrofolate, carbon dioxide, and ammonia;
methyleneTHF undergoes further oxidation with
carbon dioxide formation, the end product of this
amino acid [24]. 
The Gly cleavage systems were found not only in
neuronal cells, but also in astrocytes [29–31]. This is
consistent with abundance of metabolic reactions in
the nervous tissue in accordance with functional fea
tures of cell types. 
The brain mitochondrial Gly cleavage system
includes four components: Pprotein (pyridoxal phos
phatedependent glycine decarboxylase), Tprotein
(THFdependent aminomethyl transferase), Hpro
tein (containing lipoic acid as proton carrier), and
Lprotein (lipoamide dehydrogenase) [29–31]. 
In situ hybridization analysis has shown that pro
tein P mRNA is prefentially expressed in glialike cells
(including Bergmann glia in the cerebellum), while T
and Hprotein mRNAs are registered in neurons and
glialike cells [29]. 
Only expression of T and Hprotein mRNAs
was found in the spinal cord; the primary culture of
spinal cord astrocytes contained only the proton car
rier (Hprotein) lacking any enzymatic activity. It
should be noted that the activity of the mitochondrial
Gly cleavage system was higher in the primary culture
of rat brain cortex astrocytes than in hepatocytes [29]. 
In the spinal cord and the brainstem Gly functions
as an inhibitory neurotransmitter, while in the hippoc
ampus, brain cortex, cerebellum, and the olfactory
bulb it acts as the stimulating modulator of NMDAR
[29]. Analysis of literature data suggests that the Gly
cleavage system is involved in pathogenesis of non
ketotic hyperglycemia via modulation of NMDAR in
the anterior brain and the cerebellum. 
Consequently, Gly metabolism includes various
catabolic and anabolic processes, which have several
intersecting (crosstalk) points, and may be summa
rized into the scheme of Gly metabolism (Fig. 1).
These crosstalks allow one processes to prevail over
the other ones. For example, in rat brain astricytes the
activity of the mitochondrial Gly cleavage system in
higher than the activity of enzymes catalyzing reverse
conversion of Gly into serine and therefore probability
of Gly cleavage in astrocytes is higher than its use for
serine formation [31]. 
The spinal cord has high and low affinity systems of
Gly uptake (Km < 0.05 mM and Km > 0.1 mM, respec
tively), while the brain cortex has only the low affinity
uptake system [24].
It is generally believed that in the brain Gly is pref
erentially involved in activation of the glutamate
receptor [32, 33]: activation of NMDAR requires ago
nist concentrations of about 0.0001⎯0.1 mM. In this
case it is reasonable to suggest poor (if any) contribu
tion of the low affinity uptake system of the brain into
regulation of cortical cell functioning. 
However, it should be also noted that brain Gly
concentrations were evaluated in a pool (mass) of the
tissue or the brain cortex. The latter cannot rule out
that at certain time interval and in certain sites physi
ological concentrations of this amino acid may be rea
sonably high for involvement of the low affinity uptake
system into physiological functioning of Gly. This
problem clearly needs further investigation. 
